vor biopharma inc stock

Key stats provide selected financials for rapid company overview including. VOR including 10 year stock price and latest news.

Vor Biopharma Vorbiopharma Twitter

View daily weekly or monthly format back to when Vor Biopharma Inc.

. Discover historical prices for VOR stock on Yahoo Finance. Engages in developing cell therapies for treating cancer. Key Stock Data PE Ratio TTM NA EPS TTM -218 Market Cap 18724 M Shares Outstanding 3760 M Public Float 2493 M Yield VOR is not currently paying a regular.

A high-level overview of Vor Biopharma Inc. It is developing VOR33 an. What are analysts forecasts for Vor Biopharma stock.

By protecting healthy cells Vor Bio is aiming to delay relapse post-transplant and potentially cure AML and other blood cancers. It raised a 42 million. Market Cap 17926M Shares Out 3806M 10 Day Average Volume 012M Dividend - Dividend Yield - Beta - YTD Change -5947 RATIOSPROFITABILITY EPS.

Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. View real-time stock prices and stock quotes for a full financial overview. Vor Biopharma Inc a clinical-stage company develops engineered hematopoietic stem cell eHSC therapies for cancer patients.

All employment opportunities at. Vor Biopharma started out in 2016 when it licensed a CAR-T platform from oncologist and Pulitzer Prize winner Siddhartha Mukherjee MD PhD. Get the latest Vor Biopharma Inc VOR real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions.

Stock news by MarketWatch. Engages in developing cell therapies for treating cancer. Learn About The Science.

Vor Biopharma Inc. The 16 analysts offering price. Selected key stats of Vor Biopharma Inc.

000 VOR Real Time Quote About Vor Biopharma Inc. Back to VOR Overview. Common Stock VOR Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Pre-Market Charts NEWS ANALYSIS News Press Releases.

Real-time trade and investing ideas on Vor Biopharma Inc VOR from the largest community of traders and investors. NASDAQVORs beta value is holding at 0 while the average true range ATR indicator is currently reading 044. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to.

It is a clinical-stage cell therapy company that. According to the current price Vor Biopharma is 2560 away from the 52-week high. Rooms Rankings Earnings Newsletters Shop.

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. VOR Complete Vor Biopharma Inc. Or log in with.

Vor Biopharma Company Profile Stock Performance Earnings Pitchbook

Vor Biopharma Raises 177m In Upsized Ipo Boston Business Journal

Vor

Vor Biopharma Stock Targeted Therapies For Transplants Nasdaq Vor Seeking Alpha

Offer Letter By And Between The Registrant And Nathan Jorgensen Vor Biopharma Inc Business Contracts Justia

Vor Biopharma Stock Targeted Therapies For Transplants Nasdaq Vor Seeking Alpha

Puretech Founded Entity Vor Biopharma Announces Pricing Of Initial Public Offering Business Wire

Vor Biopharma Stock Forecast Down To 0 000001 Usd Vor Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis